Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: COVID-19 Rapid Research Funding Opportunity - Diagnostics

McMaster University

$0.00

Long-term protective immunity against SARS-CoV-2 virus in COVID-19 patients

EF 2020-21

Résumé
The current COVID-19 pandemic is caused by a new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current tests are unable to accurately identify patients who are infected or determine the effectiveness of their immune response against the virus. They also cannot identify patients who have produced a protective immune response for combating future re-infection with SARS-CoV-2. There are many question regarding the effects this pandemic has presented our society; however, understanding if individuals are protected against the virus, after being infected, continues to be very important. In this proposal, we will identify how our bodies react to the virus by examining antibodies in the immune system and by studying the memory immune cells that produce antibodies to determine if and how long our bodies are protected against the virus in the future. We will do this by identifying which patients have developed an immune response (antibodies) and then test for their ability to eliminate the SARS-CoV-2 virus, effectively. We will also determine if recovered COVID-19 patients develop memory immune cells capable of fighting re-infections in the future. These tests are important for many reasons, including: 1) accurately diagnose COVID-19 patients by identifying who developed an immune response; 2) identify individuals who mounted strong antibody responses that eliminates the SARS-CoV-2 virus and 3) determine if there is immune memory against COVID-19 that could protect against re-infection. A deeper understanding of the immune response will help fight the current COVID-19 pandemic and better prepare us for future pandemics.
Programme
Operating Grant: COVID-19 Rapid Research Funding Opportunity - Diagnostics
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
429285
Name
Nazy Ishac
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Public Health Agency of Canada
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
COVID-19 Rapid Research - Diagnostics
Projecttitle
Long-term protective immunity against SARS-CoV-2 virus in COVID-19 patients
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$0
Cihrequipment2
$0
Programname2
Operating Grant: COVID-19 Rapid Research Funding Opportunity - Diagnostics
Keyworddelim
Antibody Testing; Covid-19; Immune Protection; Immune Response; Long-Term Immunity; Memory B Cells; Neutralizating Antibodies; Sars-Cov-2
Abstract
The current COVID-19 pandemic is caused by a new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current tests are unable to accurately identify patients who are infected or determine the effectiveness of their immune response against the virus. They also cannot identify patients who have produced a protective immune response for combating future re-infection with SARS-CoV-2. There are many question regarding the effects this pandemic has presented our society; however, understanding if individuals are protected against the virus, after being infected, continues to be very important. In this proposal, we will identify how our bodies react to the virus by examining antibodies in the immune system and by studying the memory immune cells that produce antibodies to determine if and how long our bodies are protected against the virus in the future. We will do this by identifying which patients have developed an immune response (antibodies) and then test for their ability to eliminate the SARS-CoV-2 virus, effectively. We will also determine if recovered COVID-19 patients develop memory immune cells capable of fighting re-infections in the future. These tests are important for many reasons, including: 1) accurately diagnose COVID-19 patients by identifying who developed an immune response; 2) identify individuals who mounted strong antibody responses that eliminates the SARS-CoV-2 virus and 3) determine if there is immune memory against COVID-19 that could protect against re-infection. A deeper understanding of the immune response will help fight the current COVID-19 pandemic and better prepare us for future pandemics.
Competitiondate
202005
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nazy, Ishac
Approvedterm
1 an 0 mois